Clinical Trial

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

Study acronym: ACELERATE-P
Recruiting
View on ClinicalTrials.gov →
Summary
The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04 -> 2028-12 2026-08-13
minor Completion pushed: 2026-04 -> 2028-12 2026-08-13
Trial Details
NCT Number NCT06993454
Lead Sponsor AdventHealth Translational Research Institute
Conditions Type 2 Diabetes, Hepatic Steatosis
Enrollment 12 participants
Start Date 2025-04-25
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-12